Effect of treatment with tissue plasminogen activator in improving clinical status of patients with acute ischemic stroke
Phase 2
- Conditions
- Acute ischemic stroke.Cerebral infarction, unspecified
- Registration Number
- IRCT201709049014N182
- Lead Sponsor
- Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Age of 18 to 85 years; acute ischemic stroke.
Exclusion criteria: A history of acute ischemic stroke in the past 3 months; using heparin or warfarin in the past 48 hours; a history of head trauma in the past 3 months; a history of intra cranial hemorrhage; a history of myocardial infarction in the past 3 months; gastric hemorrhage in the past 3 months; a history of major surgery in the past 2 weeks; a history of convulsion.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the neurological signs. Timepoint: every 12 hours for 72 hours. Method of measurement: using NIHSS scale.
- Secondary Outcome Measures
Name Time Method